China Independent Clinical Laboratory Industry Report, 2017-2021

Publisher Name :
Date: 07-Aug-2017
No. of pages: 135
Inquire Before Buying

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States and Japan. Furthermore, Chinese independent clinical laboratories can provide more than 2,000 test items, while the counterparts in the United States can offer over 4,000 test items.

However, China's independent clinical laboratory industry is progressing rapidly, presenting the CAGR of 41.4% during 2010-2016, with the market size reaching RMB9.6 billion (an upsurge of 37.1% year on year) in 2016.

Pushed by the promotion of hierarchical medical system and other favorable policies, the growth of the outsourcing demand from public and private hospitals under the pressure of cost control, the acceleration of population aging as well as the people's ever growing awareness of health, etc., the independent clinical laboratory market size in China will maintain growth rate of at least 30% in the next five years and reach RMB41.4 billion by 2021.

As of the end of 2016, there had been 468 independent clinical laboratories in China, an increase of 112 ones over the same period of last year. They were mainly distributed in the developed coastal areas, about 50% of which were located in Shanghai, Beijing, Guangdong, Zhejiang and Jiangsu.

At present, major independent clinical laboratory companies in China include KingMed Diagnostics, ADICON, DIAN Diagnostics, DAAN Gene, Shanghai Labway Clinical Laboraory, MedicalSystem Biotechnology, Beijing Lepu Gene Technology and so forth. With cutting-edge advantages in the number of laboratories and inspection items which directly demonstrate the competitiveness of enterprises, KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene held a combined market share of over 70% in 2016. In the future, leading enterprises will continue to accelerate the chain-based expansion of laboratory network nationwide, further enhance their competitiveness, and intensify the market concentration.

China Independent Clinical Laboratory Industry Report, 2017-2021 highlights the following:


  • Overview of China’s independent clinical laboratory industry, covering policy, international environment, status quo, market size, competitive landscape and development trend;

  • Upstream and downstream sectors of China’s independent clinical laboratory industry;

  • Operation, revenue structure, gross margin and independent clinical laboratory business of 20 companies in China.

China Independent Clinical Laboratory Industry Report, 2017-2021

Table of Contents

1. Overview of Independent Clinical Laboratory
1.1 Definition
1.2 Industry Chain

2. Overview of China Independent Clinical Laboratory Industry
2.1 Policy Environment
2.1.1 Access Policy
2.1.2 Industry Policy
2.2 International Environment
2.2.1 Status Quo
2.2.2 Benchmarking Enterprises
2.3 Status Quo
2.4 Market size
2.5 Competitive Landscape
2.6 Development Trends
2.6.1 The Industry's Growth Rate Will Be Above 30% in the Next Five Years
2.6.2 Hierarchical Medical System Will Boost the Rapid Development of the Industry
2.6.3 The Laboratory Outsourcing Proportion of Public Hospitals Will Rise due to Cost Control
2.6.4 High-end Test Items Will Make More Revenue Contribution
2.6.5 The Rapid Development of Private Hospitals Will Stimulate the Demand in the Independent Clinical Laboratory Market
2.6.6 Independent Clinical Laboratory Institutions Will Become Technical Leaders amid Quick Technological Upgrades
2.6.7 The Aging Population Balloons and the Demand for Medical Laboratory Will Soar
2.6.8 Internet Will Stimulate the Business Model Upgrade of Independent Clinical Laboratory Industry

3. Upstream and Downstream Sectors of China Independent Clinical Laboratory Industry
3.1 Upstream Sector
3.1.1 Status Quo
3.1.2 Competitive Landscape
3.2 Downstream Sector
3.2.1 Quantity
3.2.2 Medical Services
3.2.3 Revenue
3.2.4 Health Costs

4. Key Players
4.1 KingMed Diagnostics
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R&D and Investment
4.1.6 Major Customers
4.1.7 Independent Clinical Laboratory Business
4.1.8 Forecast and Outlook
4.2 DIAN Diagnostics
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 R&D and Investment
4.2.6 Independent Clinical Laboratory Business
4.2.7 Forecast and Outlook
4.3 Shanghai Labway Clinical Laboratory
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D and Investment
4.3.6 Independent Clinical Laboratory Business
4.3.7 Forecast and Outlook
4.4 DAAN Gene
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 R&D and Investment
4.4.5 Major Customers
4.4.6 Independent Clinical Laboratory Business
4.4.7 Forecast and Outlook
4.5 ADICON Clinical Laboratories
4.5.1 Profile
4.5.2 Independent Clinical Laboratory Business
4.5.3 Developments
4.6 NYMPHAVN Biotechnology
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D and Investment
4.6.6 Independent Clinical Laboratory Business
4.6.7 Forecast and Outlook
4.7 SurExam Biotechnology
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 R&D and Investment
4.7.6 Independent Clinical Laboratory Business
4.7.7 Forecast and Outlook
4.8 MedicalSystem Biotechnology
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 R&D and Investment
4.8.6 Independent Clinical Laboratory Business
4.8.7 Forecast and Outlook
4.9 Beijing Lawke Health Laboratory
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Gross Margin
4.9.5 R&D and Investment
4.9.6 Forecast and Outlook
4.10 Beijing Lepu Gene Technology
4.10.1 Profile
4.10.2 Operation
4.10.3 Revenue Structure
4.10.4 Gross Margin
4.10.5 R&D and Investment
4.10.6 Major Customers
4.10.7 Forecast and Outlook
4.11 Shanghai Biotecan Pharmaceuticals
4.11.1 Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Gross Margin
4.11.5 Independent Clinical Laboratory Business
4.11.6 Forecast and Outlook
4.12 Jiangsu Superbio Life Science
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Gross Margin
4.12.5 Forecast and Outlook
4.13 Amoy Diagnostics
4.13.1 Profile
4.13.2 Operation
4.13.3 Revenue Structure
4.13.4 Gross Margin
4.13.5 Independent Clinical Laboratory Business
4.13.6 Forecast and Outlook
4.14 Guangdong Hybribio Biotech
4.14.1 Profile
4.14.2 Operation
4.14.3 Revenue Structure
4.14.4 Gross Margin
4.14.5 Independent Clinical Laboratory Business
4.14.6 Forecast and Outlook
4.15 Other Enterprises
4.15.1 Kindstar Global
4.15.2 CapitalBio Corporation
4.15.3 Beijing Adinovo Gene Technology Co., Ltd.
4.15.4 Deyi Diagnostics
4.15.5 IPE Center for Clinical Laboratory
4.15.6 Centre Testing International Group Co., Ltd. (CTI)

List of Charts

Independent Clinical Laboratory Industry Chain
Comparison of Independent Clinical Laboratory Undertakers between China and USA
Policies Concerning Independent Clinical Laboratory Industry in China, 2010-2017
Development History of U.S. Independent Clinical Laboratory Industry
U.S. Independent Clinical Laboratory Market Share by Test Item
U.S. Clinical Laboratory Market Share by Demand Side
Comparison of Independent Clinical Laboratory Market Penetration among Europe, Americas and Japan, 2016
Revenue and Net Income of Quest Diagnostics, 2009-2016
Revenue of Quest Diagnostics by Business, 2014-2016
Major M&As of Quest Diagnostics, 2006-2016
Revenue and Operating Income of LabCorp, 2010-2016
Revenue Breakdown of LabCorp by Business, 2013-2016
Major M&As of LabCorp, 2007-2017
Comparison of Independent Clinical Laboratory Market Penetration between China, and Europe, Americas and Japan, 2016
Comparison of Number of Diagnostic Items among Various Medical Institutions
Independent Clinical Laboratory Market Size in China, 2010-2016
Number of Independent Clinical Laboratories in China, 2010-2016
Independent Clinical Laboratory Revenue of Main Independent Clinical Laboratory Enterprises in China, 2014-2016
Marker Share of Independent Clinical Laboratory Enterprises in China, 2016
Comparison between Leading Independent Clinical Laboratory Companies in China, 2017
Independent Clinical Laboratory Market Size and YoY Growth in China, 2016-2021E
Policies Concerning Public Hospital Reform in China, 2015-2016
Number of Private Hospitals and YoY Growth in China, 2009-2017
Clinic Visits of Private Hospitals in China, 2012-2017
Population Aged over 60 in China, 2009-2021E
Classification of In Vitro Diagnosis
Development History of In Vitro Diagnosis Industry in China
In Vitro Diagnosis Market Size in China, 2009-2016
In Vitro Diagnosis Market Size in China, 2016-2021E
In Vitro Diagnosis Market Structure in China, 2016
Comparison of Diagnostic Instrument Varieties between Domestic and Foreign Enterprises
Competition Pattern of Diagnostic Reagent Industry in China
IVD Revenue and Market Share of Major Diagnostic Reagent Enterprises in China, 2014-2016
Number of Medical and Health Institutions in China, 2015-2017
Number of Hospitals in China, 2009-2017
Number of Hospitals in China by Economic Type, 2009-2017
Clinic Visits of Medical Institutions in China, 2015-2017
Clinic Visits of Hospitals in China, 2009-2017
Clinic Visits of Hospitals in China by Economic Type, 2012-2017
Total Revenue of Medical and Health Institutions in China, 2010-2016
Total Revenue of Medical and Health Institutions in China, 2016-2021E
Total Revenue of Hospitals in China, 2009-2016
Total Revenue of Hospitals in China, 2016-2021E
Public Hospitals’ Inspection Revenue and % of Total Inspection Revenue in China, 2010-2016
Public Hospitals’ Inspection Revenue and % of Total Inspection Revenue in China, 2016-2021E
Inspection Revenue per Outpatient Visit and Inpatient Visit of Public Hospitals in China, 2010-2015
Total Health Expenditure in China, 2010-2016
Total Health Expenditure in China, 2016-2021E
Revenue and Net Income of KingMed Diagnostics, 2014-2016
Revenue Breakdown of KingMed Diagnostics by Business, 2014-2016
Revenue Breakdown of KingMed Diagnostics by Region, 2014-2016
Gross Margin of KingMed Diagnostics, 2014-2016
Gross Margin of KingMed Diagnostics by Business, 2014-2016
R&D Costs and % of Total Revenue of KingMed Diagnostics, 2014-2016
Fundraising Projects of KingMed Diagnostics by Initial Public Offerings
KingMed Diagnostics’ Revenue from Top 5 Clients and % in Total Revenue, 2014-2016
Independent Clinical Laboratory Subsidiaries of KingMed Diagnostics
Laboratory Architecture of KingMed Diagnostics as of May 2017
Output, Capacity and Capacity Utilization of KingMed Diagnostics, 2014-2016
Unit Price of Main Services of KingMed Diagnostics, 2014-2016
Revenue and Net Income of KingMed Diagnostics, 2016-2021E
Revenue and Net Income of DIAN Diagnostics, 2013-2017
Revenue Breakdown of DIAN Diagnostics by Business, 2013-2016
Revenue Structure of DIAN Diagnostics by Business, 2013-2016
Revenue Breakdown of DIAN Diagnostics by Region, 2013-2016
Revenue Structure of DIAN Diagnostics by Region, 2013-2016
Gross Margin of DIAN Diagnostics by Business, 2013-2016
R&D Costs and % of Total Revenue of DIAN Diagnostics, 2013-2016
Independent Clinical Laboratory Subsidiaries of DIAN Diagnostics
DIAN Diagnostics’ Revenue from Independent Clinical Laboratory and % in Total Revenue, 2013-2016
Revenue and Net Income of DIAN Diagnostics, 2016-2021E
Revenue and Net Income of Shanghai Labway Clinical Laboratory, 2013-2016
Operating Revenue Breakdown of Shanghai Labway Clinical Laboratory by Business, 2013-2016
Operating Revenue Structure of Shanghai Labway Clinical Laboratory by Business, 2013-2016
Gross Margin of Shanghai Labway Clinical Laboratory by Business, 2013-2016
R&D Costs and % of Total Revenue of Shanghai Labway Clinical Laboratory, 2013-2016
Independent Clinical Laboratory Subsidiaries of Shanghai Labway Clinical Laboratory
Main Diagnostic Items of Shanghai Labway Clinical Laboratory
Shanghai Labway Clinical Laboratory’s Revenue from Independent Clinical Laboratory and % of Total Revenue, 2013-2016
Revenue and Net Income of Shanghai Labway Clinical Laboratory, 2016-2021E
Revenue and Net Income of Da An Gene, 2013-2017
Revenue Breakdown of Da An Gene by Product, 2013-2016
Revenue Structure of Da An Gene by Product, 2013-2016
Revenue Breakdown of Da An Gene by Region, 2013-2016
Revenue Structure of Da An Gene by Region, 2013-2016
R&D Costs and % of Total Revenue of Da An Gene, 2013-2016
Da An Gene’s Revenue from Top 5 Clients and % in Total Revenue, 2015-2016
Da An Gene’s Revenue from Independent Clinical Laboratory and % of Total Revenue, 2013-2016
Independent Clinical Laboratory Subsidiaries of Da An Gene
Revenue and Net Income of Da An Gene, 2016-2021E
Independent Clinical Laboratory Subsidiaries of Adicon Clinical Laboratories
Revenue and Net Income of Nymphavn Biotechnology, 2013-2016
Revenue Breakdown of Nymphavn Biotechnology by Business, 2014-2016
Gross Margin of Nymphavn Biotechnology, 2013-2016
R&D Costs and % of Total Revenue of Nymphavn Biotechnology, 2013-2016
Nymphavn Biotechnology’s Revenue from Independent Clinical Laboratory and % of Total Revenue, 2013-2016
Revenue and Net Income of Nymphavn Biotechnology, 2016-2021E
Subsidiaries and Main Businesses of SurExam Biotechnology
Revenue and Net Income of SurExam Biotechnology, 2013-2016
Operating Revenue Breakdown of SurExam Biotechnology by Business, 2013-2016
Operating Revenue Structure of SurExam Biotechnology by Business, 2013-2016
Gross Margin of SurExam Biotechnology, 2013-2016
R&D Costs and % of Total Revenue of SurExam Biotechnology, 2013-2016
SurExam Biotechnology’s Revenue from Independent Clinical Laboratory and % of Total Revenue, 2013-2016
Revenue and Net Income of SurExam Biotechnology, 2016-2021E
Revenue and Net Income of Medicalsystem Biotechnology, 2013-2017
Revenue Breakdown of Medicalsystem Biotechnology by Business, 2013-2016
Revenue Structure of Medicalsystem Biotechnology by Business, 2013-2016
Gross Margin of Medicalsystem Biotechnology by Business, 2013-2016
R&D Costs and % of Total Revenue of Medicalsystem Biotechnology, 2013-2016
Investment Progress of Fundraising Projects of Medicalsystem Biotechnology by the end of 2016
Medicalsystem Biotechnology’s Revenue from Independent Clinical Laboratory and % of Total Revenue, 2013-2016
Financial Data of Main Independent Clinical Laboratory Subsidiaries of Medicalsystem Biotechnology, 2016
Newly-established Independent Clinical Laboratory Subsidiaries of Medicalsystem Biotechnology, 2016
Revenue and Net Income of Medicalsystem Biotechnology, 2016-2021E
Revenue and Net Income of Beijing Lawke Health Laboratory, 2013-2016
Revenue Breakdown of Beijing Lawke Health Laboratory by Region, 2014-2016
Gross Margin of Beijing Lawke Health Laboratory, 2013-2016
R&D Costs and % of Total Revenue of Beijing Lawke Health Laboratory, 2013-2016
Revenue and Net Income of Beijing Lawke Health Laboratory, 2016-2021E
Revenue and Net Income of Beijing Lepu Gene Technology, 2013-2016
Revenue Breakdown of Beijing Lepu Gene Technology by Business, 2014-2016
Gross Margin of Beijing Lepu Gene Technology, 2013-2016
R&D Costs and % of Total Revenue of Beijing Lepu Gene Technology, 2014-2016
Main R&D Projects of Beijing Lepu Gene Technology, 2016
Beijing Lepu Gene Technology’s Revenue from Top 5 Clients and % in Total Revenue, 2015-2016
Revenue and Net Income of Beijing Lepu Gene Technology, 2016-2021E
Revenue and Net Income of Shanghai Biotecan Pharmaceuticals, 2013-2016
Revenue Breakdown of Shanghai Biotecan Pharmaceuticals by Business, 2014-2016
Gross Margin of Shanghai Biotecan Pharmaceuticals, 2013-2016
Shanghai Biotecan Pharmaceuticals’ Revenue from Independent Clinical Laboratory and % of Total Revenue, 2014-2016
Revenue and Net Income of Shanghai Biotecan Pharmaceuticals, 2016-2021E
Subsidiaries of Jiangsu Superbio by the end of 2016
Revenue and Net Income of Jiangsu Superbio, 2014-2016
Revenue Breakdown of Jiangsu Superbio by Business, 2014-2016
Gross Margin of Jiangsu Superbio, 2014-2016
Revenue and Net Income of Jiangsu Superbio, 2016-2021E
Revenue and Net Income of Amoy Diagnostics, 2014-2016
Operating Revenue Breakdown of Amoy Diagnostics by Business, 2014-2016
Gross Margin of Amoy Diagnostics, 2014-2016
Gross Margin of Amoy Diagnostics by Business, 2014-2016
Amoy Diagnostics’ Revenue from Independent Clinical Laboratory and % of Total Revenue, 2014-2016
Revenue and Net Income of Amoy Diagnostics, 2016-2021E
Revenue and Net Income of Guangdong Hybribio Biotech, 2014-2016
Operating Revenue Breakdown of Guangdong Hybribio Biotech by Product, 2014-2016
Gross Margin of Guangdong Hybribio Biotech by Business, 2014-2016
Guangdong Hybribio Biotech’s Revenue from Independent Clinical Laboratory and % of Total Revenue, 2014-2016
Fundraising Projects of Guangdong Hybribio Biotech by Initial Public Offerings, 2017
Revenue and Net Income of Guangdong Hybribio Biotech, 2016-2021E
Milestones of Kindstar Global
Some Strategic Partners of ADINOVO

  • Flow Cytometry Market Players--Market Shares by Country, and Strategic Assessments of Major Suppliers and Emerging Market Entrants
    Published: 14-Sep-2017        Price: US 2450 Onwards        Pages: 25
    This new report from LeadingMarketResearch.com provides strategic assessments of leading and emerging flow cytometry market players. The report presents strategic analyses of major current and emerging manufacturers of flow cytometry analyzers and consumables in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 25 pages......
  • Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 18500 Onwards        Pages: 358
    Complete report $18,500. DataPack (test volumes, sales forecasts, supplier shares) $7,400.This 7-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years. The report explores future marketing and technological trends in seven countries; provides market share estimates, test volume forecasts, and instrument placements; compares features of ......
  • Europe Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 13700 Onwards        Pages: 270
    This unique report provides information not available from any other published source, including test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers.This 5-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years. The report explores future marketing and t......
  • France Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 146
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the French flow cytometry market, including:Major issues pertaining to the French flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for major......
  • Germany Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 147
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the German flow cytometry market, including:Major issues pertaining to the German flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for major......
  • Italy Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 142
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the Italian flow cytometry market, including:Major issues pertaining to the Italian flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for maj......
  • Japan Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 4900 Onwards        Pages: 142
    Complete report $4,900. DataPack (test volumes, sales forecasts, supplier shares) $3,200.This report presents a comprehensive analysis of the Japanese flow cytometry market, including:Major issues pertaining to the Japanese flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for m......
  • Spain Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 140
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the Spanish flow cytometry market, including:Major issues pertaining to the Spanish flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for maj......
  • UK Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 146
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the UK flow cytometry market, including:Major issues pertaining to the UK flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for major flow cy......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs